Target intelligence / Profile preview

Ribosomal protein S27 pseudogene 24 (RPS27P24)

Target
RPS27P24
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S27 pseudogene 24 is a *processed pseudogene* resulting from the retrotransposition of the functional ribosomal protein S27 (RPS27) gene[1][2]. Pseudogenes like RPS27P24 are highly homologous to their parent gene but are typically intronless, lack regulatory sequences necessary for expression, and do not code for a functional protein. Unlike its protein-coding counterpart, RPS27, this pseudogene does not participate in ribosome assembly, protein synthesis, or cellular functions, nor is it associated with any disease or drug interactions. It is included in genome annotations for completeness and evolutionary studies, but it is not considered a biological or therapeutic target[4][7].\nRPS27P24 is *not* a valid molecular target (therapeutic target, receptor, enzyme, etc.), nor does it have documented interactions, functions, or disease relevance[1][2][4][7]. If you seek information on the functional gene, refer to **Ribosomal protein S27 (RPS27)** instead[3][5]. This entry exclusively addresses the pseudogene (RPS27P24), which is not an actionable biological target.

02

Mechanism of action

None

03

Biological functions

None (pseudogene; no known protein product or biological function)
04

Disease associations

None established (no protein product, so no direct role in disease)

Beyond the preview

Go deeper on Ribosomal protein S27 pseudogene 24 (RPS27P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S27 pseudogene 24 (RPS27P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call